Copyright
©The Author(s) 2002.
World J Gastroenterol. Jun 15, 2002; 8(3): 455-458
Published online Jun 15, 2002. doi: 10.3748/wjg.v8.i3.455
Published online Jun 15, 2002. doi: 10.3748/wjg.v8.i3.455
Group | Dosage | n | Body mass/g | Tumor mass -x±s/g | Inhibitary rate/% | P value | |
Beginning | End | ||||||
NS | 0.2 mL | 20 | 16.1 | 19.8 | 1.82 ± 0.95 | — | —— |
MMC | 2 μg·kg-1 | 10 | 16.2 | 19.7 | 1.07 ± 0.42 | 41.1 | < 0.05 |
RhEGF | 15 μg·kg-1 | 10 | 16.0 | 20.3 | 1.92 ± 1.04 | -5.5 | < 0.05 |
RhEGF | 30 μg·kg-1 | 10 | 16.5 | 19.8 | 1.29 ± 0.83 | 8.0 | < 0.05 |
RhEGF | 60 μg·kg-1 | 8 | 16.1 | 20.4 | 1.77 ± 1.04 | 3.1 | < 0.05 |
- Citation: Xia L, Yuan YZ, Xu CD, Zhang YP, Qiao MM, Xu JX. Effects of epidermal growth factor on the growth of human gastric cancer cell and the implanted tumor of nude mice. World J Gastroenterol 2002; 8(3): 455-458
- URL: https://www.wjgnet.com/1007-9327/full/v8/i3/455.htm
- DOI: https://dx.doi.org/10.3748/wjg.v8.i3.455